These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36733994)

  • 21. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
    J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Structural Elucidation of New Process Impurity in Testosterone.
    Gupte V; Luthra U; Desai N
    J Chromatogr Sci; 2018 May; 56(5):403-408. PubMed ID: 29554236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural identification and characterization of impurities in moxifloxacin.
    Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
    J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of impurity profiles of drugs and related materials Part 15. Identification of minor impurities in cimetidine.
    Halmos Z; Szántay C; Brlik J; Csehi A; Varga K; Horváth P; Kislaki M; Domány G; Nemes A; Görög S
    J Pharm Biomed Anal; 1996 Oct; 15(1):1-5. PubMed ID: 8895070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS.
    Raman B; Sharma BA; Ghugare PD; Karmuse PP; Kumar A
    J Pharm Biomed Anal; 2009 Oct; 50(3):377-83. PubMed ID: 19556091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.
    Nalwade SU; Reddy VR; Rao DD; Morisetti NK
    J Pharm Biomed Anal; 2012 Jan; 57():109-14. PubMed ID: 21920688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and structural elucidation of two impurities from a diacerein bulk drug.
    Ashok C; Golak M; Adwait D; Krishna V; Himani A; Umesh P; Amol G; Srinivas S; Sharad M; Deepali J; Atul C
    J Pharm Biomed Anal; 2009 Feb; 49(2):525-8. PubMed ID: 19131202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and structure elucidation of the new degradation impurities in the pharmaceutical formulations of ruxolitinib hydrobromide.
    Douša M; Doubský J; Gajdošová M; Tkadlecová M; Martinů T; Jireš J
    J Pharm Biomed Anal; 2020 Jul; 186():113266. PubMed ID: 32348952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation, identification and characterization of two novel process-related impurities in olanzapine.
    Zhuang T; Zhang W; Cao L; He K; Wang Y; Li J; Chen L; Liu B; Zhang G
    J Pharm Biomed Anal; 2018 Apr; 152():188-196. PubMed ID: 29414012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.
    Liu C; Yu Z; Wang F; Zhong X; Jiang L; Zhang F; Tang Y; Yan Z; Zeng S; Pu T
    J Chromatogr Sci; 2015 Aug; 53(7):1163-8. PubMed ID: 25644811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and identification of process impurities in trimethoprim drug substance by high-performance liquid chromatography, atmospheric pressure chemical ionization liquid chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy.
    Lehr GJ; Barry TL; Petzinger G; Hanna GM; Zito SW
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):373-89. PubMed ID: 10704103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
    J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
    Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
    J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.